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HLA-class I family includes highly polymorphic HLA-class
Ia molecules (HLA-A, HLA-B, and HLA-C), which play a
central role in adaptive immunity, and “nonclassical” HLA-
class Ib molecules (HLA-E, HLA-F, HLA-G, and HLA-H),
characterized by a limited polymorphism and a few alleles
that encode a small number of functional proteins. Both
types of HLA-class I molecules can bind peptides generated
from cytosolic antigens and present them to specific CD8+
T lymphocytes. However, the main function of HLA-class
Ib molecules is the modulation of immune responses, both
in physiological and in pathological conditions. In contrast,
nonclassical major histocompatibility complex (MHC) class I
chain related (MIC) molecules show homology with classical
human leukocyte antigen (HLA) molecules, but they do not
bind beta-2 microglobulin and peptides. Expression of MIC
proteins is upregulated on the cell surface in response to
stress, and these molecules can interact with the activating
natural killer cell receptor NKG2D, which is expressed by
many cells of the immune system.
HLA-G, the best characterized HLA-Ib molecule, was
firstly detected on fetal cytotrophoblast cells during preg-
nancy, where it abrogatesmaternal NK cell activity protecting
fetal tissues. However, HLA-G expression and release can
be detected in different cells and tissues in pathological
conditions, such as tumors, transplantation, bacterial and
viral infections, and inflamed tissues. HLA-G can interact
with at least four specific receptors (ILT2, ILT4, KIR2DL4,
and CD160) that are expressed on T and B lymphocytes,
NK cells, neutrophils, and antigen presenting cells, thus
inhibiting their functions.
HLA-E is expressed by all nucleated cells and binds
peptides derived from the leader sequence of other HLA-
class I molecules. In normal conditions, HLA-E interacts
with CD94/NKG2A inhibitory receptor on NK cells, thus
inhibiting their cytotoxicity against cells expressing HLA-
class I molecules. Transformed or virus-infected cells, which
usually downregulate HLA-class I expression, display a lower
number of HLA-class I-derived peptides. This in turn leads
to downregulation of HLA-E expression, thus allowing NK
cells lo lyse these cells. However, different transformed
cells can upregulate HLA-E expression to avoid NK cell
mediated lysis. Finally, it has been demonstrated that HLA-
E can also interact with CD94/NKG2C activatory recep-
tor, thus leading to the activation of NK cell functions.
This function is important for vascular remodeling during
pregnancy.
HLA-F can act as chaperone for the 𝛽2-microglobulin-
free heavy chain of other HLA-class I molecules, and its
expression can be detected on the surface of activated
lymphocytes. Moreover, it has been demonstrated that this
molecule can be present in a peptide-free (open conformer)
form and can cooperate with other HLA-class I open
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conformers during cross-presentation. Finally, HLA-F open
conformers can interact with different KIR on NK cells.
No functional HLA-H molecules encoded by HLA-H
alleles have been yet characterized.
In this special issue dedicated to nonclassical HLA-class
Ib molecules, we have discussed in a review novel findings
obtained in the last two years, regarding the role of HLA-
G in cancer, infectious diseases, autoimmune/inflammatory
diseases, pregnancy, and transplantation.
One interesting paper by Y. Zhang et al. addressed the
role of MICB in SLE patients. They have demonstrated that
a single nucleotide polymorphism (SNP) called rs3828903
is associated with higher susceptibility to systemic lupus
erythematosus (SLE), and a higher MICB gene expression
was detected in SLE patients, thus suggesting a role of this
molecule in the progression of the disease.
Three papers have addressed the role of HLA-E in patho-
logical conditions. J. Di Cristofaro et al. have demonstrated
that lung transplanted patients that displayed homozygosis
for HLA-E∗01:01 or HLA-E∗01:03 alleles showed impaired
overall survival as compared with patients displaying het-
erozygosis. Moreover, the presence of HLA-E∗01:03 allele
is correlated with a higher incidence of chronic rejection,
as compared with patients with HLA-E∗01:01 homozygosis.
An interesting review by S. A. Joosten et al. discussed the
role of pathogen-specific HLA-E restricted T-cell responses
during infectious diseases. Finally, F. Morandi et al. have
demonstrated that soluble HLA-E concentration was higher
in BM plasma samples from neuroblastoma patients with
metastatic disease than in those with localized tumors, thus
suggesting a role of this molecule in the progression of the
disease. The same results have been also obtained for soluble
HLA-G.
Three papers have addressed the role of HLA-G in patho-
logical conditions. G. Murdaca et al. have discussed in their
review the role of HLA-G during allergic diseases, pointing
out the role of this molecule in the suppression of the allergic
reaction. R. Rizzo and coworkers have demonstrated that
plasma sHLA-G levels were higher in women with primary
human congenital cytomegalovirus (HCMV) infection than
in nonprimary and uninfected pregnant women. Moreover,
sHLA-G levels in amniotic fluid were higher in symptomatic
than in asymptomatic fetuses. Collectively, these data sug-
gested a role for HLA-G as a biomarker for HCMV infection.
L. L. Olesen and T. V. F. Hviid have characterized the role
of HLA-G in left ventricular systolic dysfunction (LVSD).
They have demonstrated that soluble HLA-G was higher in
patients with ejection fraction (EF) < 50% than in those
with EF > 50%. However, sHLA-G was less specific as a
biomarker of LVSD than other classic biomarkers. Moreover,
a combined 14 bp ins-del/+3142SNP HLA-G haplotype was
associated with EF < 40%.
Finally, an interesting review by L. L. Johansen and
coworkers discussed the role of classical and nonclassi-
cal HLA-class I molecules in the progression of human
melanoma.
Collectively, all these papers have added novel important
findings on HLA-class Ib molecules in different settings, thus
confirming their pivotal role in the control of the immune
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